✦ LIBER ✦

Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis

✍ Scribed by Christophe Corpechot; Farid Gaouar; Yves Chrétien; Catherine Johanet; Olivier Chazouillères; Raoul Poupon

Book ID: 116652472
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 824 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2011.03.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum surrogate markers of liver fibrosi

Serum surrogate markers of liver fibrosis in primary biliary cirrhosis

✍ Argiro Voumvouraki; Mairi Koulentaki; George Notas; Ourania Sfakianaki; Elias Ko 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 553 KB

660 IS SMOKING A RISK FACTOR OF MORE SEV

660 IS SMOKING A RISK FACTOR OF MORE SEVERE DISEASE IN PRIMARY BILIARY CIRRHOSIS?

✍ C. Corpechot; F. Gaouar; Y. Chrétien; O. Chazouillères; R. Poupon 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Anti-centromere antibody is an independe

Anti-centromere antibody is an independent risk factor for chronic kidney disease in patients with primary biliary cirrhosis

✍ Shintaro Mandai, Eiichiro Kanda, Yohei Arai, Suguru Hirasawa, Toshiyuki Hirai, S 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 188 KB

Primary Biliary Cirrhosis, An Issue of C

Primary Biliary Cirrhosis, An Issue of Clinics in Liver Disease

✍ Sanjiv Chopra 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 136 KB

The effect of ursodeoxycholic acid thera

The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis

✍ Christophe Corpechot; Fabrice Carrat; Anne-Marie Bonnand; Renée Eugénie Poupon; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Prediction of clinical outcomes in prima

Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay

✍ Marlyn J. Mayo; Julie Parkes; Beverley Adams-Huet; Burton Combes; A. S. Mills; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 1 views

Primary biliary cirrhosis (PBC) is sometimes diagnosed based on a positive antimitochondrial antibody in the appropriate clinical setting without a liver biopsy. Although a liver biopsy can assess the extent of liver fibrosis and provide prognostic information, serum fibrosis markers avoid biopsy co